 Pre-Exposure Prophylaxis
"Pre-Exposure Prophylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.
| Descriptor ID |
D065129
|
| MeSH Number(s) |
N02.421.726.758.655 N06.850.780.680.655
|
| Concept/Terms |
Pre-Exposure Prophylaxis- Pre-Exposure Prophylaxis
- Pre Exposure Prophylaxis
- Pre-Exposure Prophylaxi
- Prophylaxi, Pre-Exposure
- Prophylaxis, Pre-Exposure
- Pre-Exposure Prophylaxis (PrEP)
- Pre Exposure Prophylaxis (PrEP)
- Pre-Exposure Prophylaxi (PrEP)
- Prophylaxi, Pre-Exposure (PrEP)
- Prophylaxis, Pre-Exposure (PrEP)
|
Below are MeSH descriptors whose meaning is more general than "Pre-Exposure Prophylaxis".
Below are MeSH descriptors whose meaning is more specific than "Pre-Exposure Prophylaxis".
This graph shows the total number of publications written about "Pre-Exposure Prophylaxis" by people in this website by year, and whether "Pre-Exposure Prophylaxis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 3 | 1 | 4 | | 2015 | 4 | 2 | 6 | | 2016 | 9 | 0 | 9 | | 2017 | 14 | 2 | 16 | | 2018 | 18 | 5 | 23 | | 2019 | 12 | 5 | 17 | | 2020 | 11 | 4 | 15 | | 2021 | 31 | 2 | 33 | | 2022 | 22 | 0 | 22 | | 2023 | 17 | 0 | 17 | | 2024 | 17 | 1 | 18 | | 2025 | 18 | 2 | 20 | | 2026 | 9 | 1 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Pre-Exposure Prophylaxis" by people in Profiles.
-
Irie WC, Corneli A, Perry B, Kelsey C, Bickham J, Davenport T, Naresh A, Holman S, Clement M. Start the Conversation: Development of a Training Program to Build OB/GYN Resident Capacity for PrEP Prescribing in Routine Care. J Int Assoc Provid AIDS Care. 2026 Jan-Dec; 25:23259582261488339.
-
Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson PL, Myer L, Celum C, Heffron R, Coleman J, Davey DLJ, Zhang L, von Kleist M, Hendrix CW, Momper JD, Bies R, Scott RK. Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum. J Clin Pharmacol. 2026 Sep; 66(9):e70278.
-
Tagliaferri Rael C, Das D, Giguere R, Porter J, Bryndza Tfaily E, Tuswa Haynes C, Ho T, McKenna S, Lopez-Ríos J, Lentz C, Dolezal C, Stonbraker S, Hendrix C, D'Aquila RT, Hope TJ. Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa. AIDS Res Hum Retroviruses. 2026 Oct-Nov; 42(10-11):307-317.
-
Puccinelli M, Mayer KH, Esquivel-Mendoza JA, Porras A, Psaros C, Krakower D, Doblecki-Lewis S, Anderson PL, Mimiaga MJ, Safren SA. Life-steps for PrEP nurse-delivered adherence intervention: Protocol for a multisite randomized clinical trial. Contemp Clin Trials. 2026 Sep; 168:108405.
-
Torres TS, Silva MST, Hoagland B, Marins LMS, Coutinho C, Jalil EM, Leite P, Cunha M, Moreira R, Leite IC, Konda K, Guanira J, Benedetti M, Pimenta C, Vega-Ramirez H, Cardoso SW, Caceres CF, Anderson PL, Grinsztejn B, Veloso VG. Using Tenofovir Diphosphate Levels to Evaluate Factors Associated With PrEP Non-Adherence and Performance of Indirect Adherence Measures in Latin America: A Prospective, Single-Arm, Open-Label, Multicentre Implementation Study (ImPrEP). J Int AIDS Soc. 2026 Jul; 29 Suppl 3:e70154.
-
Valentin OR, Henderson C, Coffin LS, Paredes-Gotamco J, Olem D, Farrales W, Neilands TB, Dilworth SE, Doblecki-Lewis S, Page K, Moskowitz JT, Anderson PL, Johnson MO, Carrico AW. Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial. BMJ Open. 2026 May 11; 16(5):e120232.
-
Hampanda K, Amstutz A, Nayame L, Sehrt M, Hamoonga T, Menon JA, Mumbula I, Mulawa M, Nkole E, Matenga FJ, Mugode M, Mweemba O. TwySHE-an mHealth peer-navigator intervention to increase PrEP and contraceptive use among female university students in Zambia: study protocol of a hybrid effectiveness-implementation randomized controlled trial. Trials. 2026 Mar 05; 27(1).
-
Mhlanga FG, Szydlo DW, Mayo AJ, Bunge K, Fairlie L, Nakabiito C, Musara P, Mgodi NM, Dadabhai S, Scheckter R, Anderson PL, Marzinke MA, Chappell C, Gadama LA, Richardson BA, Piper JM, Hillier SL. Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial. Lancet HIV. 2026 Mar; 13(3):e176-e184.
-
Llibre JM, Iniesta C, Tittle V, Clement M, Rivero Á, Armenteros-Yeguas I, Álvarez-López P, Ryan P, Arribas JR, Moreno S. Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations. J Antimicrob Chemother. 2026 Feb 02; 81(3).
-
Ustianowski A, Levin MJ, De Wit S, Launay O, Veekmans B, Rampling T, Sullivan JG, Vishnepolsky M, Wijewardane P, Fawadleh Y, Zhang H, Li M, Wickramarachchi D, Sharbaugh A, Beavon R, Thissen J, Hirao L, Dzutseva V, Seegobin S, Streicher K, Kiazand A, Esser MT, Chang LJ, Perez JL, Cohen TS. Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study. Clin Drug Investig. 2026 Feb; 46(2):207-219.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|